Closed · RFA-FD-14-089 · CFDA 93.103 · Discretionary

Critical Path Public Private Partnerships

Federal grant opportunity posted by Food and Drug Administration, cataloged on Grants.gov.

$1.5M-$10.5M
Award range
Closed
Status
July 28, 2014
Close date
1
Expected awards

The verdict

Critical Path Public Private Partnerships is a closed discretionary listing from Food and Drug Administration that offered $1,500,000 -- $10,500,000 across 1 expected award. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 481 other opportunities from Food and Drug Administration.

$1.5M-$10.5M
award range
Closed
application status
1
expected award
93.103
CFDA program

Archived opportunity record

Critical Path Public Private Partnerships is closed (last close July 28, 2014). The parent program page for CFDA 93.103 is the reliable place to catch re-announcements. Food and Drug Administration still indexes 481 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed July 28, 2014

Posted Jun 19 Closes Jul 28

Est. Total Funding

$10,500,000

Expected Awards

1

Instrument

Cooperative Agreement

Description

As part of its Critical Path Initiative, FDA recognizes the need for collaborations established under the terms and conditions of a cooperative agreement, whereby existing resources and expertise can be used to the fullest extent possible. The Critical Path Institute has developed 8 individual consortia – the Coalition Against Major Disease Consortium (CAMD), the Multiple Sclerosis Outcome Assessment Consortium (MSOAC), the Patient Reported Outcomes Consortium (PRO), the Electronic Patient Reported Outcomes Consortium (ePRO), the Coalition for Accelerating Standards and Therapies (CFAST), the Predictive Safety Testing Consortium (PSTC), the Polycystic Kidney Disease Outcome Consortium (PKD), and the Critical Path to TB Drug Regimens Consortium (CPTR). These consortia have been active in developing biomarkers and Clinical Outcome Assessment Tools for Qualification under the FDA’s Drug Development Tool Qualification Program. The goals of this program are to maintain the administrative and scientific infrastructure of these consortia efforts while continuing to support the creation and execution of ongoing and new projects (such as a Neonatal Consortium) under the FDA's Critical Path Initiative.

Campus–civic applicant bridge · 4 doors

Critical Path Public Private Partnerships bridges educational institutions with civic applicant types (4 doors: Public / state-controlled institutions of higher education; Nonprofits with 501(c)(3) status (other than IHEs); Nonprofits without 501(c)(3) status (other than IHEs); Private institutions of higher education). Expect campus and public/nonprofit operators in the same printed set. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity codes span Food and Nutrition · Health (FN;HL). Only 1 other Food and Drug Administration listing share this exact eligibility-code string (0% of 482).

Code 06
Public / state-controlled institutions of higher education
Code 12
Nonprofits with 501(c)(3) status (other than IHEs)
Code 13
Nonprofits without 501(c)(3) status (other than IHEs)
Code 20
Private institutions of higher education

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

Daniel Lukash Grants Management Specialist Phone 240-402-7596

What to do next

Critical Path Public Private Partnerships is closed; use the parent program and agency catalog for the next funding cycle.

  • Parent CFDA 93.103 may publish future NOFOs under the same assistance listing. Open program
  • Food and Drug Administration Research indexes 42 Grants.gov listings in this extract. Program profile
  • Food and Drug Administration lists 481 other indexed opportunities on PlainGrants. Agency catalog

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants